FITC anti-human HLA-A2 Antibody
- 产品名称：
- FITC anti-human HLA-A2 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 343303
- 产品应用：
- 343303
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1212 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Papain solubilized HLA-A2
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
The BB7.2 antibody recognizes human leukocyte antigen (HLA) A2 which is a subset of MHC-class I molecules encoded by A*02 alleles.
Additional reported applications (for the relevant formats) include: immunoprecipitation3.
- Application References
(PubMed link indicates BioLegend citation) -
- Brodsky FM, et al. 1979. Immunol. Rev. 47:3.
- Parham P and Brodsky FM. et al. 1981. Hum. Immunol. 3:277.
- Lubben NB, et al. 2007. Mol Biol Cell. 18:3351. (IP)
- Product Citations
-
- Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
- Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
- Xiao C, et al. 2022. iScience. 25:103934. PubMed
- Dean L, et al. 2015. Forensic Sci Int. 17: 8-16. PubMed
- Wu W, et al. 2020. Oncol Lett. 0.91875. PubMed
- Kerstein A, et al. 2016. J Autoimmun. S0896-8411(16)30186-X. PubMed
- Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
- Su S, et al. 2017. Cell Res. 10.1038/cr.2017.34. PubMed
- Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
- Huygens C, et al. 2015. J Biol Chem. 290: 20105-20116. PubMed
- Meng J, et al. 2010. Clin Vaccine Immunol. 1.325694444. PubMed
- Morvan MG, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
- Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
- Pan X, et al. 2021. Front Pharmacol. 11:539261. PubMed
- RRID
- AB_1659246 (BioLegend Cat. No. 343303) AB_1659245 (BioLegend Cat. No. 343304)
